Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.50)
# 2,245
Out of 4,854 analysts
2
Total ratings
50%
Success rate
24.52%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $6.85
Upside: +45.99%